Three Key Aspects of Risk Management during Phase 3 Clinical Trials
Venue: Online
Location: Online, United States
Event Date/Time: Apr 23, 2008 | End Date/Time: Apr 23, 2008 |
Description
•Incorporate a Risk MAP within a pre-marketing clinical trial;
•Evaluate clinical trial data as a basis for developing a RiskMAP strategy; and
•Use the phase 3 program to test and refine Risk MAP tools.